Merck & Co., Inc.·4

May 1, 5:43 PM ET

Zachary Jennifer 4

Research Summary

AI-generated summary

Updated

Merck EVP/General Counsel Jennifer Zachary Converts RSUs, Sells Shares

What Happened
Jennifer Zachary, EVP and General Counsel of Merck & Co. (MRK), had 2,951 restricted stock units (RSUs) vest and convert into common shares on 2026-04-29. The shares were valued at $110.03 each for a total value of $324,699. To satisfy tax withholding, 1,454 of those shares were disposed (sold) at $110.03 for proceeds of $159,984, leaving a net 1,497 shares retained (approx. $164,715 in value).

Key Details

  • Transaction date: 2026-04-29; Form 4 filed 2026-05-01 (appears timely).
  • Conversion: 2,951 RSUs converted to 2,951 shares at $110.03 each (total $324,699).
  • Tax withholding/disposition: 1,454 shares disposed at $110.03 (proceeds $159,984).
  • Net shares retained: 1,497 (2,951 received - 1,454 withheld), net value ≈ $164,715.
  • Footnotes: F1 = each RSU converts to one share; F2 = these RSUs vest in three equal installments (4/29/2026, 4/29/2027, 4/29/2028).
  • Filing timeliness: no late filing flag shown.

Context
This was a routine RSU vesting event with shares converted and a portion withheld/sold to cover taxes (common practice). It’s not an open-market purchase or discretionary sale that would necessarily signal a change in insider sentiment. The filing does not indicate a 10b5-1 plan or other trading arrangement.